The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)methyl)-3,4,6-trimethylthieno[2,3-b]pyridine-2-carboxamide ID: ALA4467950
PubChem CID: 41358726
Max Phase: Preclinical
Molecular Formula: C20H20N2O3S
Molecular Weight: 368.46
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(C)c2c(C)c(C(=O)NCc3ccc4c(c3)OCCO4)sc2n1
Standard InChI: InChI=1S/C20H20N2O3S/c1-11-8-12(2)22-20-17(11)13(3)18(26-20)19(23)21-10-14-4-5-15-16(9-14)25-7-6-24-15/h4-5,8-9H,6-7,10H2,1-3H3,(H,21,23)
Standard InChI Key: MNPAUPZTLSHYKE-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
1.7527 -9.5256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7515 -10.3451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4596 -10.7541 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4578 -9.1167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4553 -8.2996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1664 -9.5220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1666 -10.3452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9496 -10.5994 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.4333 -9.9332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9492 -9.2675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2505 -9.9329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6594 -10.6405 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6589 -9.2251 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4765 -10.6402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0435 -10.7532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8854 -11.3478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4741 -12.0528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8823 -12.7599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6980 -11.3431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2015 -8.4902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1081 -12.0420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7047 -12.7586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1213 -13.4625 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9431 -13.4558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3465 -12.7392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9282 -12.0292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 7 2 0
6 4 2 0
4 1 1 0
4 5 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
9 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
2 15 1 0
14 16 1 0
16 17 2 0
17 18 1 0
18 22 2 0
21 19 2 0
19 16 1 0
10 20 1 0
21 22 1 0
21 26 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 368.46Molecular Weight (Monoisotopic): 368.1195AlogP: 3.92#Rotatable Bonds: 3Polar Surface Area: 60.45Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.00CX LogP: 3.60CX LogD: 3.60Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.76Np Likeness Score: -1.79
References 1. Poslusney MS, Salovich JM, Wood MR, Melancon BJ, Bollinger KA, Luscombe VB, Rodriguez AL, Engers DW, Bridges TM, Niswender CM, Conn PJ, Lindsley CW.. (2019) Novel M4 positive allosteric modulators derived from questioning the role and impact of a presumed intramolecular hydrogen-bonding motif in β-amino carboxamide-harboring ligands., 29 (3): [PMID:30580918 ] [10.1016/j.bmcl.2018.12.039 ]